Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshihiko Hirohashi

Showing results (1-10 of 233) with videos related to

Pageof 24
Sort By:
Immunotherapy|August 17, 2011
Tumor-associated dendritic cells: molecular mechanisms to suppress antitumor immunityYoshihiko Hirohashi, Noriyuki Sato
Immunotherapy|December 1, 2012
Depletion of Tregs in vivo: a promising approach to enhance antitumor immunity without autoimmunityRena Morita, Yoshihiko Hirohashi, Noriyuki Sato
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 14, 2019
[PD-L1-Mediated Immune Escape Mechanism of Cancer Stem-Like Cells]Masahiro Matsuki, Yoshihiko Hirohashi, Toshihiko Torigoe
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|November 1, 2016
Dendritic cell and cancer immune checkpointTerufumi Kubo, Yoshihiko Hirohashi, Toshihiko Torigoe
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 2, 2013
Constitutive expression and activation of stress response genes in cancer stem-like cells/tumour initiating cells: potent targets for cancer stem cell therapyToshihiko Torigoe, Yoshihiko Hirohashi, Kazuyo Yasuda, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
Development of next-generation peptide vaccination therapyTomohide Tsukahara, Yoshihiko Hirohashi, Makoto Emori, et al.
Experimental and Molecular Pathology|October 4, 2006
DIPA, which can localize to the centrosome, associates with p78/MCRS1/MSP58 and acts as a repressor of gene transcriptionXiulian Du, Qiang Wang, Yoshihiko Hirohashi, et al.
Experimental and Molecular Pathology|December 26, 2009
Nek2 targets the mitotic checkpoint proteins Mad2 and Cdc20: a mechanism for aneuploidy in cancerQingdu Liu, Yoshihiko Hirohashi, Xiulian Du, et al.
Oncoimmunology|July 9, 2015
HLA class I as a predictor of clinical prognosis and CTL infiltration as a predictor of chemosensitivity in ovarian cancerYoshihiko Hirohashi, Toshihiko Torigoe, Tasuku Mariya, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 20, 2014
[The path to innovative drug development of cancer vaccine: from discovery of tumor antigens to clinical trials]Toshihiko Torigoe, Yoshihiko Hirohashi, Tomohide Tsukahara, et al.
Pageof 24

Showing results (1-10 of 233) with videos related to

Sort By:
Pageof 24
Immunotherapy|August 17, 2011
Tumor-associated dendritic cells: molecular mechanisms to suppress antitumor immunityYoshihiko Hirohashi, Noriyuki Sato
Immunotherapy|December 1, 2012
Depletion of Tregs in vivo: a promising approach to enhance antitumor immunity without autoimmunityRena Morita, Yoshihiko Hirohashi, Noriyuki Sato
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 14, 2019
[PD-L1-Mediated Immune Escape Mechanism of Cancer Stem-Like Cells]Masahiro Matsuki, Yoshihiko Hirohashi, Toshihiko Torigoe
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|November 1, 2016
Dendritic cell and cancer immune checkpointTerufumi Kubo, Yoshihiko Hirohashi, Toshihiko Torigoe
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 2, 2013
Constitutive expression and activation of stress response genes in cancer stem-like cells/tumour initiating cells: potent targets for cancer stem cell therapyToshihiko Torigoe, Yoshihiko Hirohashi, Kazuyo Yasuda, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
Development of next-generation peptide vaccination therapyTomohide Tsukahara, Yoshihiko Hirohashi, Makoto Emori, et al.
Experimental and Molecular Pathology|October 4, 2006
DIPA, which can localize to the centrosome, associates with p78/MCRS1/MSP58 and acts as a repressor of gene transcriptionXiulian Du, Qiang Wang, Yoshihiko Hirohashi, et al.
Experimental and Molecular Pathology|December 26, 2009
Nek2 targets the mitotic checkpoint proteins Mad2 and Cdc20: a mechanism for aneuploidy in cancerQingdu Liu, Yoshihiko Hirohashi, Xiulian Du, et al.
Oncoimmunology|July 9, 2015
HLA class I as a predictor of clinical prognosis and CTL infiltration as a predictor of chemosensitivity in ovarian cancerYoshihiko Hirohashi, Toshihiko Torigoe, Tasuku Mariya, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 20, 2014
[The path to innovative drug development of cancer vaccine: from discovery of tumor antigens to clinical trials]Toshihiko Torigoe, Yoshihiko Hirohashi, Tomohide Tsukahara, et al.
Pageof 24